Pre-exposure prophylaxis in the perinatal period.
作者信息
Schwartz Sheree, Saidi Friday
机构信息
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
University of North Carolina Project Malawi, Lilongwe, Malawi; Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, NC, USA; Department of Obstetrics and Gynecology, Kamuzu University of Health Sciences, Lilongwe, Malawi.
出版信息
Lancet HIV. 2024 Nov;11(11):e720-e721. doi: 10.1016/S2352-3018(24)00244-3.
Abstract
摘要
相似文献
1
Pre-exposure prophylaxis in the perinatal period.围产期暴露前预防。
Lancet HIV. 2024 Nov;11(11):e720-e721. doi: 10.1016/S2352-3018(24)00244-3.
2
Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.为预防艾滋病毒向孕妇和产后妇女提供暴露前预防：一种临床方法。
J Int AIDS Soc. 2017 Mar 8;20(Suppl 1):21295. doi: 10.7448/IAS.20.2.21295.
3
A Missed Opportunity for U.S. Perinatal Human Immunodeficiency Virus Elimination: Pre-exposure Prophylaxis During Pregnancy.美国围产期消除人类免疫缺陷病毒的一个错失的机会：孕期暴露前预防
Obstet Gynecol. 2017 Oct;130(4):703-709. doi: 10.1097/AOG.0000000000002258.
4
Perinatal outcomes associated with pre-exposure prophylaxis for HIV prevention during pregnancy: a systematic review and meta-analysis.孕期预防艾滋病病毒暴露前预防的围产期结局：一项系统评价和荟萃分析。
EClinicalMedicine. 2024 Mar 19;70:102532. doi: 10.1016/j.eclinm.2024.102532. eCollection 2024 Apr.
5
Perinatal outcomes following maternal pre-exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya.孕期使用母体暴露前预防（PrEP）的围产期结局：肯尼亚大型 PrEP 实施项目的结果。
J Int AIDS Soc. 2019 Sep;22(9):e25378. doi: 10.1002/jia2.25378.
6
Perinatal Antibiotic Exposure Affects the Transmission between Maternal and Neonatal Microbiota and Is Associated with Early-Onset Sepsis.围产期抗生素暴露会影响母婴微生物群之间的传播，并与早发性败血症有关。
mSphere. 2020 Feb 19;5(1):e00984-19. doi: 10.1128/mSphere.00984-19.
7
Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?一项针对孕妇和产后妇女暴露前预防安全性的系统评价的新证据：我们现在在哪里，我们的目标在哪里？
J Int AIDS Soc. 2020 Jan;23(1):e25426. doi: 10.1002/jia2.25426.
8
Implementing pre-exposure prophylaxis for HIV prevention in women: the role of the obstetrician-gynecologist.在女性中实施暴露前预防以预防艾滋病病毒：妇产科医生的作用。
Am J Obstet Gynecol. 2022 Jun;226(6):764-772. doi: 10.1016/j.ajog.2021.12.263. Epub 2021 Dec 29.
9
Changes in HIV post-exposure prophylaxis prescriptions before and after the introduction of HIV pre-exposure prophylaxis at a sexual health clinic in Melbourne, Australia, 2011-2021.2011-2021 年澳大利亚墨尔本一家性健康诊所引入 HIV 暴露前预防措施前后 HIV 暴露后预防处方的变化。
Aust N Z J Public Health. 2024 Aug;48(4):100179. doi: 10.1016/j.anzjph.2024.100179. Epub 2024 Jul 24.
10
Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.美国两家医疗中心在孕前、产前和产后期间使用艾滋病毒暴露前预防药物的情况。
Am J Obstet Gynecol. 2016 Nov;215(5):632.e1-632.e7. doi: 10.1016/j.ajog.2016.06.020. Epub 2016 Jul 19.
本文引用的文献
1
Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study.南非孕妇和产后妇女启动和持续使用口服暴露前预防措施（PrEP-PP）：一项演示队列研究。
Lancet HIV. 2024 Nov;11(11):e746-e755. doi: 10.1016/S2352-3018(24)00240-6.
2
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.双年度利纳卡帕韦或每日 F/TAF 用于预防 cisgender 女性中的 HIV。
N Engl J Med. 2024 Oct 3;391(13):1179-1192. doi: 10.1056/NEJMoa2407001. Epub 2024 Jul 24.
3
Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub-Saharan Africa community stakeholders.将孕妇和哺乳期妇女纳入新型长效暴露前预防药物试验：撒哈拉以南非洲社区利益相关者的观点
J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26120. doi: 10.1002/jia2.26120.
4
Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa.南非女性性工作者和青少年女性中暴露前预防用药的起始、持续和循环的纵向模式。
AIDS. 2023 May 1;37(6):977-986. doi: 10.1097/QAD.0000000000003500. Epub 2023 Jan 31.
5
Human Immunodeficiency Virus Treatment and Prevention for Pregnant and Postpartum Women in Global Settings.全球范围内孕产妇的人类免疫缺陷病毒治疗和预防。
Obstet Gynecol Clin North Am. 2022 Dec;49(4):693-712. doi: 10.1016/j.ogc.2022.07.002.
6
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action.加速妊娠中新 HIV 药物的研究：将研究议程从理论推进到实践。
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25912. doi: 10.1002/jia2.25912.
7
HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.在非洲为少女和年轻妇女提供艾滋病毒暴露前预防：从疗效试验到推广。
J Int AIDS Soc. 2019 Jul;22 Suppl 4(Suppl Suppl 4):e25298. doi: 10.1002/jia2.25298.
8
Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis.妊娠和产后期间的 HIV 事件与母婴 HIV 传播风险：系统评价和荟萃分析。
PLoS Med. 2014 Feb 25;11(2):e1001608. doi: 10.1371/journal.pmed.1001608. eCollection 2014 Feb.
9
Representation of women and pregnant women in HIV research: a limited systematic review.HIV 研究中女性和孕妇的代表性：一项有限的系统评价。
PLoS One. 2013 Aug 23;8(8):e73398. doi: 10.1371/journal.pone.0073398. eCollection 2013.
Zotero 插件